Deborah H. Charych - Feb 14, 2023 Form 3 Insider Report for Skye Bioscience, Inc. (SKYE)

Role
Director
Signature
/s/ Kaitlyn Arsenault, as Attorney-in-Fact
Stock symbol
SKYE
Transactions as of
Feb 14, 2023
Transactions value $
$0
Form type
3
Date filed
2/16/2023, 04:36 PM
Next filing
Mar 3, 2023

No securities are beneficially owned.

Remarks:

No securities are beneficially owned. Exhibit 24 - Power of Attorney.